Michael Harty (Clare, Independent) | Oireachtas source

We are now meeting representatives from the Health Products Regulatory Authority to discuss abortion medication as envisaged in the termination of pregnancy legislation. On behalf of the committee, I welcome Mr. John Lynch and Dr. Elaine Breslin from the authority. I apologise to them for keeping them so long. Our previous session overran.

I draw the attention of witnesses to the fact that by virtue of section 17(2)(l) of the Defamation Act 2009, they are protected by absolute privilege in respect of their evidence to the joint committee. However, if they are directed by the committee to cease giving evidence on a particular matter and they continue to do so, they are entitled thereafter only to qualified privilege in respect of their evidence. They are directed that only evidence connected with the subject matter of these proceedings is to be given. They are asked to respect the parliamentary practice to the effect that, where possible, they should not criticise or make charges against any person, persons or entity by name or in such a way as to make him, her or it identifiable.

Members are reminded of the long-standing parliamentary practice to the effect that they should not comment on, criticise or make charges against a person outside the Houses or an official by name or in such a way as to make him or her identifiable.

I advise the witnesses that any opening statements they make will be published on the committee's website after the meeting. I invite Dr. Elaine Breslin to make her opening statement.